Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Witherspoon

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Bone Marrow Transplantation|September 1, 1988
Transfer of specific immunity in marrow recipients given HLA-mismatched, T cell-depleted, or HLA-identical marrow graftsL G Lum, J E Noges, P Beatty, et al.
Blood|September 1, 1985
Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow graftsP J Martin, J A Hansen, C D Buckner, et al.
Bone Marrow Transplantation|March 1, 1992
Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experienceM E Flowers, K C Doney, R Storb, et al.
Neurology|August 1, 1986
Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host diseaseG B Bolger, K M Sullivan, A M Spence, et al.
The New England Journal of Medicine|September 13, 1990
Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantationK M Sullivan, K J Kopecky, J Jocom, et al.
Bone Marrow Transplantation|September 1, 1988
Use of thymic grafts or thymic factors to augment immunologic recovery after bone marrow transplantation: brief report with 2 to 12 years' follow-upR P Witherspoon, K M Sullivan, L G Lum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from SeattleF B Petersen, F R Appelbaum, R Hill, et al.
Bone Marrow Transplantation|December 1, 1986
Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiationH J Deeg, K M Sullivan, C D Buckner, et al.
Blood|August 1, 1981
Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatmentR P Witherspoon, R Storb, H D Ochs, et al.
Blood|December 12, 2001
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trialE Kansu, T Gooley, M E Flowers, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Bone Marrow Transplantation|September 1, 1988
Transfer of specific immunity in marrow recipients given HLA-mismatched, T cell-depleted, or HLA-identical marrow graftsL G Lum, J E Noges, P Beatty, et al.
Blood|September 1, 1985
Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow graftsP J Martin, J A Hansen, C D Buckner, et al.
Bone Marrow Transplantation|March 1, 1992
Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experienceM E Flowers, K C Doney, R Storb, et al.
Neurology|August 1, 1986
Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host diseaseG B Bolger, K M Sullivan, A M Spence, et al.
The New England Journal of Medicine|September 13, 1990
Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantationK M Sullivan, K J Kopecky, J Jocom, et al.
Bone Marrow Transplantation|September 1, 1988
Use of thymic grafts or thymic factors to augment immunologic recovery after bone marrow transplantation: brief report with 2 to 12 years' follow-upR P Witherspoon, K M Sullivan, L G Lum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from SeattleF B Petersen, F R Appelbaum, R Hill, et al.
Bone Marrow Transplantation|December 1, 1986
Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiationH J Deeg, K M Sullivan, C D Buckner, et al.
Blood|August 1, 1981
Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatmentR P Witherspoon, R Storb, H D Ochs, et al.
Blood|December 12, 2001
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trialE Kansu, T Gooley, M E Flowers, et al.
Pageof 11